Главная
Study mode:
on
1
Intro
2
Objectives
3
Background
4
Why now
5
Case
6
Initial regimens
7
Dose and toxicities
8
What happened to the patient
9
Betalactamases
10
What happened in the interim
11
Emergency use protocol
12
The silent epidemic
13
New drugs
14
Empirical approach
15
Other infections
16
Conclusion
Description:
Explore the urgent public health issue of carbapenem-resistant Acinetobacter spp. infections in this 44-minute video featuring expert discussions with Dr. Yohei Doi and Dr. Joseph Patrick Hornak. Delve into the scarcity of antibiotic options, potential new drugs on the horizon, and current treatment strategies. Learn about betalactamases, emergency use protocols, and the silent epidemic of these infections. Gain insights on empirical approaches, dose considerations, toxicities, and management of other related infections. Understand the background, objectives, and latest developments in treating this challenging bacterial threat through real-world case studies and expert analysis.

Treatment of Acinetobacter spp. Infections

American Society for Microbiology
Add to list
0:00 / 0:00